Chest Department, CIUSSS du Nord-de-l'île-de-Montréal, Montréal, QC, Canada; Chest Department, Université de Montréal, Montréal, QC, Canada.
Chest Department, CIUSSS du Nord-de-l'île-de-Montréal, Montréal, QC, Canada; Chest Department, Université de Montréal, Montréal, QC, Canada.
J Allergy Clin Immunol Pract. 2024 Nov;12(11):2977-2982. doi: 10.1016/j.jaip.2024.07.021. Epub 2024 Jul 31.
Specific inhalation challenge (SIC) tests are still the reference test for diagnosing sensitizer-induced occupational asthma (SIOA). The European Respiratory Society recommends the cessation of inhaled corticosteroids (ICS) 72 hours before SIC.
To assess the effect of an ongoing ICS treatment during SIC on the maximum fall in forced expiratory volume in 1 second (FEV), the change in methacholine provocative concentration of methacholine inducing a 20% fall in FEV (PC), and sputum eosinophil counts after exposure to the suspected agent.
We performed a retrospective analysis using a database of cases referred to our center for suspected SIOA from 1999 to 2022. The results of the SIC were compared between subjects treated with ICS during SIC and steroid-naïve subjects.
Six hundred and seventy-one individuals underwent SIC in the laboratory. Three hundred and eighteen were treated with ICS, whereas 353 were steroid naïve. The proportion of subjects with a positive SIC was greater among ICS-treated subjects (39. 6%) compared with steroid-naïve subjects (27.5%, P < .001). A treatment with ICS did not influence the outcome of the SIC. There was no difference in the change in PC or the percentage of sputum eosinophils after SIC between steroid-treated and steroid-naïve subjects.
An ongoing ICS treatment during an SIC did not affect the occurrence of an asthmatic reaction, the change in airway responsiveness, or eosinophilic inflammation after exposure to the suspected agent in subjects who have been treated with ICS for a long period of time.
特异性吸入挑战(SIC)测试仍然是诊断变应原引起的职业性哮喘(SIOA)的参考测试。欧洲呼吸学会建议在 SIC 前 72 小时停止吸入皮质类固醇(ICS)。
评估 SIC 期间持续 ICS 治疗对 1 秒用力呼气量(FEV)最大下降、乙酰甲胆碱激发浓度引起 FEV 下降 20%(PC)的变化以及暴露于可疑物质后痰中嗜酸性粒细胞计数的影响。
我们使用从 1999 年至 2022 年我们中心因疑似 SIOA 而转诊的病例数据库进行了回顾性分析。比较了在 SIC 期间接受 ICS 治疗的受试者和未接受类固醇治疗的受试者的 SIC 结果。
671 人在实验室进行了 SIC。318 人接受 ICS 治疗,353 人未接受类固醇治疗。与未接受类固醇治疗的受试者(27.5%,P<.001)相比,接受 ICS 治疗的受试者中 SIC 阳性的比例更高(39.6%)。ICS 治疗并不影响 SIC 的结果。在 SIC 后气道反应性的变化或痰中嗜酸性粒细胞的百分比方面,接受 ICS 治疗的受试者与未接受 ICS 治疗的受试者之间没有差异。
在长期接受 ICS 治疗的受试者中,SIC 期间持续 ICS 治疗不会影响哮喘反应的发生、气道反应性的变化或暴露于可疑物质后嗜酸性粒细胞炎症。